Kandepres 16

Candesartan cilexetil, the active ingredient in Kandepres 16, is an Angiotensin II receptor blocker (ARB) presented as an oral tablet for oral use. It is used to treat hypertension and may be prescribed for other cardiovascular conditions in appropriate patients.

GNH USA supplies Kandepres 16 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kandepres 16, an Angiotensin II receptor blocker, is employed in the management of several cardiovascular conditions.

- Hypertension: lowers elevated blood pressure and reduces the risk of stroke and heart attack. - Heart failure: improves symptoms and decreases hospitalisation in patients with reduced ejection fraction. - Diabetic nephropathy: slows the progression of kidney damage in patients with type 2 diabetes.

Adverse reactions may occur with candesartan therapy. They are categorized by frequency and severity.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially after standing. - Headache: mild to moderate intensity. - Fatigue: feeling unusually tired. - Abdominal pain: discomfort in the stomach area. - Cough: dry or mild cough. - Hyperkalaemia: elevated blood potassium levels.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or throat. - Severe hypotension: markedly low blood pressure causing fainting. - Acute renal impairment: sudden decline in kidney function. - Hepatic dysfunction: abnormal liver enzyme elevations. - Neutropenia: reduced white blood cell count. - Anaphylaxis: life‑threatening allergic reaction.

Before initiating therapy, clinicians should consider several safety measures.

- Blood pressure monitoring: ensure adequate control and avoid excessive lowering. - Renal function assessment: check serum creatinine and eGFR regularly. - Serum potassium evaluation: monitor for hyperkalaemia, especially with concomitant potassium‑sparing agents. - Hepatic impairment caution: dose adjustment may be required in patients with liver disease. - Hypersensitivity awareness: discontinue if signs of allergic reaction appear. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Candesartan can interact with other medicines, influencing safety or effectiveness.

Major Interactions (Avoid): - ACE inhibitors: combined use increases risk of hyperkalaemia and renal dysfunction. - Potassium‑sparing diuretics or supplements: may cause dangerous elevations in serum potassium. - Aliskiren (in diabetic patients): heightened risk of hypotension, renal impairment, and hyperkalaemia.

Moderate Interactions (Monitor Closely): - NSAIDs: can reduce antihypertensive effect and impair renal function. - Diuretics: may require dose adjustment of candesartan to maintain blood pressure control.